Synaptogenix Files 2024 10-K, Details Financial Inputs
Ticker: TAOX · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1571934
| Field | Detail |
|---|---|
| Company | Synaptogenix, Inc. (TAOX) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceutical, financials
TL;DR
Synaptogenix 2024 10-K is in! Financials and fair value inputs detailed. #investing
AI Summary
Synaptogenix, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Neurotrope Bioscience, Inc., is in the pharmaceutical preparations industry. The filing details financial inputs and fair value measurements, including risk-free interest rates and expected terms related to private placements in September 2024 and November 2022.
Why It Matters
This filing provides investors with a comprehensive overview of Synaptogenix's financial health and operational details for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Synaptogenix faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for the 10-K.)
- 20250327 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Synaptogenix, Inc. (company) — Filer of the 10-K
- Neurotrope Bioscience, Inc. (company) — Former name of Synaptogenix, Inc.
- 2024-12-31 (date) — Fiscal year end
- September 2024 (date) — Date of a private placement
- November 2022 (date) — Date of a private placement
FAQ
What is the primary business of Synaptogenix, Inc.?
Synaptogenix, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was Synaptogenix, Inc. formerly known as?
Synaptogenix, Inc. was formerly known as Neurotrope Bioscience, Inc., with a name change date of March 12, 2013.
What is the fiscal year end for this 10-K filing?
The fiscal year end for this 10-K filing is December 31, 2024.
What are some of the financial inputs mentioned in the filing?
The filing mentions inputs such as risk-free interest rate, expected term, and default rate, related to private placements in September 2024 and November 2022.
Where is Synaptogenix, Inc. located?
Synaptogenix, Inc.'s business and mailing address is 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Synaptogenix, Inc. (TAOX).